Association Between Early Markers of Renal Injury and Type 2 Diabetic Peripheral Neuropathy

References

• Zheng Y , Ley SH , Hu FB . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol . 2018;14(2):88–98. doi:10.1038/nrendo.2017.151 29219149
   PubMed Web of Science ®Google Scholar
• Pop-Busui R , Boulton AJ , Feldman EL , et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care . 2017;40(1):136–154. doi:10.2337/dc16-2042 27999003
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 11. microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care . 2021;44(Supplement 1):S151–S167. doi:10.2337/dc21-S011 33298422
   PubMed Web of Science ®Google Scholar
• Aggarwal HK , Sood S , Jain D , et al. Evaluation of spectrum of peripheral neuropathy in predialysis patients with chronic kidney disease. Ren Fail . 2013;35(10):1323–1329. doi:10.3109/0886022X.2013.828261 23964701
   PubMed Web of Science ®Google Scholar
• Issar T , Arnold R , Kwai NCG , et al. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients. Clin Neurophysiol . 2019;130(11):2088–2095. doi:10.1016/j.clinph.2019.08.005 31541986
   PubMed Web of Science ®Google Scholar
• Zhang Y , Jiang Y , Shen X , et al. Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus? Neurol Sci . 2017;38(8):1381–1390. doi:10.1007/s10072-017-2946-1 28478497
   PubMed Web of Science ®Google Scholar
• Kim SR , Lee YH , Lee SG , et al. Urinary N-acetyl-beta-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes. Medicine . 2016;95(27):e4114. doi:10.1097/MD.0000000000004114 27399115
   PubMed Web of Science ®Google Scholar
• Ekrikpo UE , Effa EE , Akpan EE , et al. Clinical utility of urinary beta 2-microglobulin in detection of early nephropathy in African diabetes mellitus patients. Int J Nephrol . 2017;2017:4093171. doi:10.1155/2017/4093171 28250988
   PubMedGoogle Scholar
• Levey AS , Coresh J , Balk E , et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med . 2003;139(2):137–147. doi:10.7326/0003-4819-139-2-200307150-00013 12859163
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl . 2013;3:1–150.
   Web of Science ®Google Scholar
• Liu X , Xu Y , An M , et al. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS One . 2019;14(2):e212574.
   PubMed Web of Science ®Google Scholar
• Wu F , Jing Y , Tang X , et al. Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients. Acta Diabetol . 2017;54(10):925–931. doi:10.1007/s00592-017-1025-7 28730568
   PubMed Web of Science ®Google Scholar
• Jasti DB , Mallipeddi S , Apparao A , et al. A clinical and electrophysiological study of peripheral neuropathies in predialysis chronic kidney disease patients and relation of severity of peripheral neuropathy with degree of renal failure. J Neurosci Rural Pract . 2017;8(4):516–524. doi:10.4103/jnrp.jnrp_186_17 29204008
   PubMedGoogle Scholar
• Feldman EL , Nave KA , Jensen TS , et al. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron . 2017;93(6):1296–1313. doi:10.1016/j.neuron.2017.02.005 28334605
   PubMed Web of Science ®Google Scholar
• Lai YR , Cheng BC , Huang CC , et al. Correlation between kidney and peripheral nerve functions in type 2 diabetes. QJM . 2020;113(3):173–180.31584675
   PubMed Web of Science ®Google Scholar
• Kaewput W , Thongprayoon C , Rangsin R , et al. The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study. Hosp Pract . 2019;47(1):46–52. doi:10.1080/21548331.2019.1549916
   Google Scholar
• Hong CY , Chia KS , Ling SL . Urinary protein excretion in type 2 diabetes with complications. J Diabetes Complications . 2000;14(5):259–265. doi:10.1016/S1056-8727(00)00119-7 11113688
   PubMed Web of Science ®Google Scholar
• Zhang WR , Parikh CR . Biomarkers of acute and chronic kidney disease. Annu Rev Physiol . 2019;81(1):309–333. doi:10.1146/annurev-physiol-020518-114605 30742783
   PubMed Web of Science ®Google Scholar
• Mise K , Hoshino J , Ueno T , et al. Prognostic value of tubulointerstitial lesions, urinary N-acetyl-beta-d-glucosaminidase, and urinary beta2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. Clin J Am Soc Nephrol . 2016;11(4):593–601. doi:10.2215/CJN.04980515 26801478
   PubMed Web of Science ®Google Scholar
• Holm J , Nielsen NV , Hemmingsen L . Retinopathy in type II diabetes mellitus associated with above-normal urinary excretion of RBP. Kidney Int Suppl . 1994;47:S105–S108.7869657
   PubMed Web of Science ®Google Scholar
• Canaud B , Morena M , Cristol JP , Krieter D . Beta2-microglobulin, a uremic toxin with a double meaning. Kidney Int . 2006;69(8):1297–1299. doi:10.1038/sj.ki.5000389 16612412
   PubMed Web of Science ®Google Scholar
• Kopf S , Oikonomou D , Zdunek D , et al. Urinary n-acetyl-beta-d-glucosaminidase excretion: an indicator of neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes . 2013;121(10):601–606. doi:10.1055/s-0033-1355384 24057510
   PubMed Web of Science ®Google Scholar
• Takao T , Horino T , Kagawa T , et al. Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells. J Nephrol . 2011;24(2):218–224. doi:10.5301/JN.2010.5785 20890878
   PubMed Web of Science ®Google Scholar
• Sun SC . The non-canonical NF-kappaB pathway in immunity and inflammation. Nat Rev Immunol . 2017;17(9):545–558. doi:10.1038/nri.2017.52 28580957
   PubMed Web of Science ®Google Scholar
• Brownlee M . The pathobiology of diabetic complications: a unifying mechanism. Diabetes . 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615 15919781
   PubMed Web of Science ®Google Scholar